Skip to content
Screener

MiMedx Group MDXG Total Liabilities

Total Liabilities at other companies

IAR
Integra LifeSciencesIART
$2.52B-4.2%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$33.82M-34.8%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$118.31M+18.4%
Solventum logo
SolventumSOLV
$9.44B-17.4%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$55.83M-28.5%
CorMedix logo
CorMedixCRMD
$378.59M+991%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$622.4M-40.2%
Enterprise value$503.76M-46.5%
P/E99.8×+67.4×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemJune 30,2026December 31,2025
Total current liabilities38,49864,266
Long term debt, net15,70616,467
Other liabilities10,7915,372
Total liabilities$64,995$86,105
Stockholders' equity
Common stock; $0.001 par value; 250,000,000 shares authorized; 149,188,840 issued and 145,724,441 outstanding at June 30, 2026 and 148,093,920 issued and outstanding at December 31, 2025149148
Additional paid-in capital297,094299,081
Treasury stock at cost; 3,464,399 shares at June 30, 2026 and 0 shares at December 31, 2025(12,859)

Item 1. Financial Statements

FAQ

What is MiMedx Group's total liabilities?
MiMedx Group (MDXG) reported total liabilities of $65M in Q2 2026.
How has MiMedx Group's total liabilities changed year-over-year?
MiMedx Group's total liabilities decreased by 12.7% year-over-year, from $74.49M to $65M.
What is the long-term trend for MiMedx Group's total liabilities?
Over 5 years (2020 to 2025), MiMedx Group's total liabilities has grown at a -4.9% compound annual growth rate (CAGR), from $110.61M to $86.11M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about MiMedx Group's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude